GANAB expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 1.8711998617249E-10 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.75169999999869E-05 |
Normal-vs-Stage2 |
8.30120000000489E-05 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
2.992600E-04 |
Stage1-vs-Stage2 |
3.755200E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
6.648800E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
5.637200E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
8.01790001059288E-09 |
Normal-vs-AfricanAmerican |
1.921980E-01 |
Normal-vs-Asian |
3.227900E-02 |
Caucasian-vs-AfricanAmerican |
4.422600E-01 |
Caucasian-vs-Asian |
5.987000E-01 |
AfricanAmerican-vs-Asian |
1.849230E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
6.824600E-04 |
Normal-vs-Female |
1.01209995939655E-09 |
Male-vs-Female |
9.405200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.77794999999259E-05 |
Normal-vs-Extreme_Weight |
2.586100E-04 |
Normal-vs-Obese |
3.951600E-04 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
1.275580E-01 |
Normal_Weight-vs-Obese |
8.211800E-02 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
8.545600E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.249400E-01 |
Normal-vs-Age(41-60Yrs) |
9.168800E-04 |
Normal-vs-Age(61-80Yrs) |
6.97980007124954E-10 |
Normal-vs-Age(81-100Yrs) |
4.385000E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.616200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.997400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.781600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.447230E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.774600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.869360E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
6.109600E-01 |
Normal-vs-Grade 3 |
5.330800E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
2.699400E-01 |
Grade 2-vs-Grade 4 |
6.109600E-01 |
Grade 3-vs-Grade 4 |
5.330800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.82910000040759E-07 |
Normal-vs-N1 |
3.320400E-03 |
N0-vs-N1 |
8.096000E-01 |
|
|